Working... Menu

A Study of Famitinib in Patients With Advanced Non-squamous and Non-Small Cell Lung Cancer (NSCLC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02356991
Recruitment Status : Active, not recruiting
First Posted : February 6, 2015
Last Update Posted : January 18, 2019
Sun Yat-sen University
Shanghai Pulmonary Hospital, Shanghai, China
Information provided by (Responsible Party):
Jiangsu HengRui Medicine Co., Ltd.

No Study Results Posted on for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : June 2019
  Estimated Study Completion Date : June 2019